| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.56B | 57.12B | 58.95B | 69.29B | 49.74B | 33.28B |
| Gross Profit | 12.32B | 10.91B | 12.52B | 16.11B | 10.10B | 7.01B |
| EBITDA | 5.15B | 5.61B | 7.25B | 9.93B | 6.74B | -557.00M |
| Net Income | 1.24B | 1.76B | 3.17B | 4.25B | 2.50B | -3.29B |
Balance Sheet | ||||||
| Total Assets | 68.54B | 63.19B | 61.63B | 59.96B | 56.25B | 49.30B |
| Cash, Cash Equivalents and Short-Term Investments | 9.38B | 6.43B | 8.43B | 9.01B | 7.84B | 5.51B |
| Total Debt | 20.28B | 12.19B | 10.56B | 13.36B | 14.49B | 15.56B |
| Total Liabilities | 40.10B | 34.09B | 32.56B | 33.99B | 33.46B | 28.76B |
| Stockholders Equity | 25.47B | 26.49B | 26.20B | 25.29B | 22.41B | 20.30B |
Cash Flow | ||||||
| Free Cash Flow | 1.76B | 240.00M | 2.22B | 4.30B | 2.77B | 852.00M |
| Operating Cash Flow | 5.59B | 4.96B | 6.51B | 7.83B | 4.68B | 2.74B |
| Investing Cash Flow | -3.53B | -2.69B | -5.85B | -4.10B | -2.93B | 222.00M |
| Financing Cash Flow | -1.45B | -1.64B | -3.05B | -2.83B | -529.00M | -1.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $56.89B | 18.64 | 5.31% | 5.41% | -3.84% | 15.75% | |
78 Outperform | $201.23B | 14.38 | 8.06% | 3.92% | -6.96% | 0.03% | |
76 Outperform | $21.45B | 16.91 | 5.00% | 5.18% | -4.83% | -41.69% | |
69 Neutral | $60.18B | 11.15 | 13.46% | 7.43% | 1.53% | -35.81% | |
69 Neutral | $74.15B | 5.54 | 18.20% | 14.10% | -11.63% | -15.67% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |